article thumbnail

Welcome to new Director David Hulcoop

The Open Targets Blog

David Hulcoop, previously Strategy and Operations Director for the consortium, starts as Executive Director of Open Targets in October 2023. This involves scaling up the process of making a few grams of the compound in the lab to hundreds of tonnes in a factory, in an environmentally-friendly, cost-effective way.

article thumbnail

Metabolism of macrocyclic drugs

Metabolite Tales Blog

A combination therapy of glecaprevir and pibrentasvir has recently been implicated in a case of liver injury. Figure 2 Human metabolism of glecaprevir Involvement of gut bacteria Grazoprevir (MK5172) is also used as part of combination therapy to treat chronic hepatitis C. Journal of Medicinal Chemistry, 66 (8), 5377-5396.

article thumbnail

Metabolism of de novo designed macrocyclic drugs

Metabolite Tales Blog

A combination therapy of glecaprevir and pibrentasvir has recently been implicated in a case of liver injury. Figure 2 Human metabolism of glecaprevir Involvement of gut bacteria Grazoprevir (MK5172) is also used as part of combination therapy to treat chronic hepatitis C. Journal of Medicinal Chemistry, 66 (8), 5377-5396.